Top Companies in the Endoscope Reprocessing

The global endoscope reprocessing market is projected to reach USD 4.24 billion by 2030 from USD 2.71 billion in 2025, at a CAGR of 9.4% during the forecast period.

Endoscope reprocessing plays a crucial role in protecting patient safety and effective infection control across healthcare settings. It involves a detailed multistep process of cleaning, disinfecting, drying, storing, and preparing endoscopes for safe reuse. Since endoscopes are reusable instruments used in diagnostic and surgical procedures, they can become contaminated if not properly reprocessed. The endoscope reprocessing ecosystem includes various products such as equipment like automated endoscope reprocessors (AERs), drying, storage, and transport systems, as well as consumables like detergents, wipes, high-level disinfectants, test strips, and other reprocessing supplies. Additionally, it involves endoscope tracking solutions. These products are designed to meet international regulatory standards to ensure safety, prevent infection transmission, and maintain device integrity. Widely used in hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics, endoscope reprocessing supports high procedural throughput, minimizes cross-contamination risk, and improves operational efficiency—ultimately leading to better patient outcomes in both diagnostic and therapeutic endoscopic procedures.

To know about the assumptions considered for the study download the pdf brochure

Notable companies in this market include ASP (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Hoya Corporation (Japan), Conmed Corporation (US), Miele (Germany), Endo-Technik W. Griesat GmbH (UK), FUJIFILM Holdings Corporation (Japan), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), and Metrex Research, LLC. (Canada), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), Medonica Co. Ltd. (South Korea), Shinva Medical Instrument Co. Ltd. (China), Micro-Scientific, LLC (US), Medalkan (Greece), Medical Devices Group Srl (Italy), SBSystem (Italy), Olive Health Care (India), MMM Group (Germany), Amity International (UK), and MIXTA MEDIKAL (Turkey), among others. The leading companies in the market focus on higher sales, acquisitions, partnerships, joint ventures, product launches, and expansions.

Steris (Ireland) is a leading player in the global endoscope reprocessing market, with a strong presence across North America, Europe, and the Asia Pacific. STERIS is a top provider of products and services focused on infection prevention. As of March 2024, the company employed 18,000 people operating in over 100 countries across Asia, Europe, Latin America, South America, and North America through its field sales and service facilities, along with a network of dealers and distributors. The company owns 52 contact sterilization facilities and leases 12 across the Americas, Europe, and Asia. Over the past three years, investments in R&D and product innovation have been key strategies for the company’s long-term growth. In 2024, 2023, and 2022, the company’s R&D expenses were USD 107.6 million, USD 103.6 million, and USD 98.4 million, respectively. Aside from R&D, the company collaborates with other market players to reduce external sourcing of innovations. It also plans to expand its global presence and strengthen its marketing and manufacturing capabilities.

ASP (US) ranks as the second-largest player in the endoscope reprocessing market, holding a significant market share in 2024. It has extensive geographic coverage through its manufacturing facilities, subsidiaries, and distributors across all regions. The demand from existing businesses in the Advanced Healthcare Solutions segment increased in both developed and high-growth markets in 2024, driven by higher demand for endoscope reprocessing equipment and consumables, especially from growth in North America and Asia. ASP also prioritizes creating the safest environment for patients and healthcare providers worldwide. In this effort, it established a Centre of Excellence Program that recognizes hospitals dedicated to high infection prevention. Guy’s & St Thomas’ NHS Foundation Trust, one of the UK’s largest hospital trusts, works with Essentia (UK) (the in-house sterile service unit of Guy’s and St Thomas’s) and is an officially recognized ASP Centre of Excellence. As part of this program, ASP hosts conferences, training sessions, educational seminars, and site visits led by infection prevention experts and scientists across Europe, the Middle East, and Africa.

Olympus Corporation (Japan) was recognized as the third leading player in the endoscope reprocessing market in 2024. The company has a dedicated business segment that focuses on solutions in the field of endoscopy, enhancing its product offerings in related markets. Operating in over 40 countries, Olympus supports global distribution, local manufacturing hubs, and quick technical service, which are essential for strong market penetration. The company mainly concentrates on R&D activities to introduce innovative products. Importantly, during the fiscal year ending March 31, 2025, the Olympus Group invested USD 693.05 million (YEN 103,890 million) in research and development, highlighting its commitment to innovation across various product lines, including hygiene and safety systems. Additionally, its brand reputation, compliance with international hygiene standards, and deep understanding of clinical needs give Olympus a significant advantage over regional and less-integrated competitors.

Market Ranking

The endoscope reprocessing market is led by major players such as STERIS (Ireland), ASP (US), Olympus Corporation (Japan), Getinge AB (Sweden), and Ecolab (US), who together hold about 55–60% of the total market. This ranking was created through extensive secondary research and validated by industry experts' opinions. It considers key factors like revenue from endoscope reprocessing products, the diversity and quality of their offerings, and their commitment to innovation. Furthermore, acquisitions, partnerships, joint ventures, product launches, expansions, and other developments have significantly influenced their market standing. These companies continue to lead due to their strong presence, comprehensive solutions, and continuous advancements in endoscope reprocessing.

Related Reports:

Endoscope Reprocessing Market by Product (AER, HLD & Test Strip, Detergent & Wipe, Endoscope Drying, Storage, & Transport System, Tracking Solution), Endoscope Type (Flexible, Rigid), End User (Hospital, ASC, Specialty Clinic) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com